Publikationen in Zusammenarbeit mit Forschern von Hospital Clínico Universitario Lozano Blesa (1)

2021

  1. Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- And high-risk myeloma

    Blood, Vol. 137, Núm. 1, pp. 49-60